Carcinoma of unknown primary site represents a heterogeneous group of malignancies that present with lymph node or distant metastases, for which diagnostic work-up fails to identify the site of origin. Their incidence relative to total head and neck cancers ranges from as low as 1.7 to 2.5%. Malignant cervical lymphadenopathy is occasionally caused by neoplasms from primary sites outside the head and neck region. Here we present a case series of patients diagnosed with cervical lymph node metastasis of unknown origin(MUO neck) and that of remote areas. Electronic database was searched for cases of cervical lymph node metastasis, that were operated or underwent any type of biopsy from August 2018 till February 2024. Details of patients diagnosed with neck metastasis of unknown origin and remote primary were compiled in the form of case series. The incidence of neck metastasis of unknown origin was found to be 1.1%. Two cases of cervical lymph node metastasis from the sites outside the head and neck were found, out of which one case was of breast cancer while the other was cholangiocarcinoma. IHC has a significant role to play in all these conditions. Pointing out exact tumor histology shall open avenues for specific targeted therapy in these metastatic settings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890884PMC
http://dx.doi.org/10.1007/s12070-024-05218-1DOI Listing

Publication Analysis

Top Keywords

lymph node
20
cervical lymph
16
node metastasis
16
metastasis unknown
16
unknown origin
12
case series
12
head neck
12
origin remote
8
remote primary
8
sites head
8

Similar Publications

Objectives: To assess the prognostic impact of adequate lymphadenectomy and determine the optimal nodal assessment for different clinical stages of lung cancer.

Methods: We retrospectively reviewed 1214 patients with clinical stage I-III non-small cell lung cancer who had preoperative PET/CT and curative surgery (2006-2017). Patients were categorized based on whether they had adequate [R0] or inadequate lymphadenectomy [R(un)].

View Article and Find Full Text PDF

Clinical significance of positron emission tomography-computed tomography in the classification of thymic tumors.

Interdiscip Cardiovasc Thorac Surg

March 2025

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Objectives: This study aimed to explore the possibility of positron emission tomography/computed tomography (PET-CT) in identifying histological classification of thymic tumors.

Methods: Patients diagnosed as thymic tumors and accepted PET-CT scans were included. Thymic tumors were classified into three subgroups: low risk thymoma (A, AB and B1), high risk thymoma (B2, B3) and thymic carcinoma (TC).

View Article and Find Full Text PDF

Objectives: Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small cell lung cancer.

Methods: A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤ 2 cm non-small cell lung cancers were included.

View Article and Find Full Text PDF

Objectives: To develop a deep learning (DL) model based on ultrasound (US) images of lymph nodes for predicting cervical lymph node metastasis (CLNM) in postoperative patients with differentiated thyroid carcinoma (DTC).

Methods: Retrospective collection of 352 lymph nodes from 330 patients with cytopathology findings between June 2021 and December 2023 at our institution. The database was randomly divided into the training and test cohort at an 8:2 ratio.

View Article and Find Full Text PDF

B cell depletion is an efficacious therapy for multiple sclerosis, but its long-term safety profile in the gastrointestinal tract has not been specifically studied. This is of importance because the gut is the largest reservoir of IgA in the body, which maintains gut homeostasis in part by regulating the composition of the gut microbiota. This was addressed by development of a prolonged B cell depletion model using human CD20 transgenic mice and B cell depletion with the anti-human CD20 antibodies rituximab, a humanized mouse monoclonal, and 2H7, the mouse precursor to ocrelizumab.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!